Cargando…
Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data
Hidradenitis suppurativa (HS) is a relapsing, inflammatory disease characterized by painful nodules, abscesses, sinuses track formation and scarring. HS has a great impact on patients’ quality of life and its treatment may be really challenging. Adalimumab provides a new therapeutic option for HS. O...
Autores principales: | Kyriakou, Aikaterini, Trigoni, Anastasia, Galanis, Nikiforos, Sotiriadis, Dimitrios, Patsatsi, Aikaterini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187007/ https://www.ncbi.nlm.nih.gov/pubmed/30370041 http://dx.doi.org/10.4081/dr.2018.7859 |
Ejemplares similares
-
Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa
por: Fotiadou, Christina, et al.
Publicado: (2016) -
Adalimumab Effect on Pain in Hidradenitis Suppurativa Patients: Systematic Review and Meta-Analysis
por: Tsentemeidou, Aikaterini, et al.
Publicado: (2022) -
Serum Levels of TNF-α, IL-12/23p40, and IL-17 in Plaque Psoriasis and Their Correlation with Disease Severity
por: Kyriakou, Aikaterini, et al.
Publicado: (2014) -
Association of Autoantibodies to BP180 with Disease Activity in Greek Patients with Bullous Pemphigoid
por: Patsatsi, Aikaterini, et al.
Publicado: (2012) -
Interstitial Granulomatous Dermatitis: Another Clinical Variant
por: Patsatsi, Aikaterini, et al.
Publicado: (2011)